News and updates from Epicyt Pharma will be published here
Press release
All News | Company news | Press releases
Company news will be published here
7 September, 2026
We develop the
drug candidate BAFA
Epicyt Pharma AB
Visiting and postal address:
c/o Business Control Partner Norden AB
Krokslätts Fabriker 30, SE-431 37 Mölndal, Sweden
invoice@epicytpharma.com
Epicyt Pharma AB is a Gothenburg-based pharmaceutical R&D company whose development effort is focused on calcium absorption in the intestine and how this affects the bone health. The company was founded in 2014 when the scientist Lars Fändriks and Ville Wallenius together with a group of investors decided to exploit the discovery.
Press release
All News | Company news | Press releases
7 September, 2026
News and updates from Epicyt Pharma will be published here
To provide the best experience, we use technologies such as cookies to store and/or access device information. Consenting to these technologies allows us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may negatively affect certain features and functions.